Kati Shihadeh

Pharmacology Consult

A closer look at drug discoveries and developments that affect clinical practice.

Pharmacology Consult

Fighting HAIs requires synergy of coordinated efforts

Infectious Disease News, February 2020
Kimberly Boeser, PharmD, MPH, BCIDP
It likely goes without saying that two of the most integral steps to fighting hospital-acquired infections are practicing antimicrobial stewardship…
Pharmacology Consult

Cefiderocol: A novel siderophore cephalosporin for MDR gram-negative infections

Infectious Disease News, January 2020
Leah Molloy, PharmD
Multidrug-resistant (MDR) gram-negative bacteria continue to present an important threat to public health, and a long-stagnating antibiotic pipeline…
Pharmacology Consult

Vector-borne illness of stealth: The current state of Lyme disease diagnostics, treatment and research

Infectious Disease News, December 2019
Bailey N. Kernan, PharmD; Kati Shihadeh, PharmD, BCIDP
Lyme disease was first described in the United States in 1975, after two concerned mothers in Old Lyme, Connecticut, reached out to rheumatologists…
Pharmacology Consult

The coming of age of rapid ART initiation in HIV

Infectious Disease News, November 2019
Jeff Brock, PharmD, MBA, BCPS-AQ ID
When to begin ART once HIV diagnosis is confirmed has been an area of research and debate for many years. The standard of care in the United States…
Pharmacology Consult

Antihistamines, part II: Long-term adverse effects?

Infectious Diseases in Children, November 2019
Edward A. Bell, PharmD, BCPS
The last Pharmacology Consult column, “Antihistamines for the common cold: Where’s the evidence?” (September 2019), reviewed…
Pharmacology Consult

Preventing and treating flu in immunocompromised patients: 2019-2020 update

Infectious Disease News, September 2019
Selena Warminski, PharmD; Leah Molloy, PharmD
Influenza remains an important threat to public health, and people with impaired immune systems are at particularly high risk for severe disease and…
Pharmacology Consult

Hepatitis B vaccine shortage: Unknown impact on future disease

Infectious Disease News, August 2019
Kimberly Boeser, PharmD, MPH, BCIDP
Drug shortages continue to inundate our health care system. They have paralyzed pharmacies and affected hundreds of thousands of patients. Although…
Pharmacology Consult

Nasal decolonization: potential mupirocin alternatives for SSI prevention

Infectious Disease News, July 2019
Jeff Brock, PharmD, MBA, BCPS-AQ ID
Staphylococcus aureus nasal carriage is a proven risk factor for the development of staphylococcal surgical site infections, or SSIs. S. aureus
Pharmacology Consult

The good, bad and unnecessary prescribing of oral vancomycin prophylaxis in immunosuppressed patients

Infectious Disease News, June 2019
Jennifer Ross, PharmD; Kimberly D. Boeser, PharmD, MPH, BCIDP
Clostridioides difficile infection, or CDI, continues to be a significant pathogen in both hospitals and community-based settings. The associated…
Pharmacology Consult

Mechanisms of carbapenem resistance: CP or not CP? Is that the question?

Infectious Disease News, May 2019
Leah Molloy, PharmD
Carbapenem-resistant Enterobacteriaceae, or CRE, pose an important threat to public health and a treatment challenge to clinicians. Further…